No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs536982590 |
chr5:177556580-177556581 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs73349806 |
chr5:177556615-177556616 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs192415301 |
chr5:177556635-177556636 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs533625261 |
chr5:177556647-177556648 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs114189905 |
chr5:177556649-177556650 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs368600032 |
chr5:177556660-177556661 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs202028643 |
chr5:177556669-177556670 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs548733056 |
chr5:177556675-177556676 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs78527507 |
chr5:177556679-177556680 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs148261376 |
chr5:177556680-177556681 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs537437826 |
chr5:177556705-177556706 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs555785262 |
chr5:177556734-177556735 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs574366097 |
chr5:177556748-177556749 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs542139789 |
chr5:177556752-177556753 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs62392207 |
chr5:177556811-177556812 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs560053238 |
chr5:177556863-177556864 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs368938587 |
chr5:177556867-177556868 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs540331125 |
chr5:177556868-177556869 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs565371530 |
chr5:177556966-177556967 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs532700804 |
chr5:177557001-177557002 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs139173699 |
chr5:177557009-177557010 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs562906144 |
chr5:177557017-177557018 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs530297357 |
chr5:177557080-177557081 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs575109899 |
chr5:177557085-177557086 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs9329130 |
chr5:177557107-177557108 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs184524090 |
chr5:177557130-177557131 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs9329131 |
chr5:177557145-177557146 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs375796680 |
chr5:177557204-177557205 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs185506165 |
chr5:177557229-177557230 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs552392662 |
chr5:177557236-177557237 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs377660730 |
chr5:177557263-177557264 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs537575947 |
chr5:177557264-177557265 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs138309194 |
chr5:177557331-177557332 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs574386915 |
chr5:177557356-177557357 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs535356002 |
chr5:177557417-177557418 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs554047450 |
chr5:177557418-177557419 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs572293522 |
chr5:177557428-177557429 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs545977359 |
chr5:177557463-177557464 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs141977320 |
chr5:177557522-177557523 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs577401472 |
chr5:177557535-177557536 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs73349808 |
chr5:177557542-177557543 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs546779446 |
chr5:177557555-177557556 |
Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs10058984 |
chr5:177557633-177557634 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs542116503 |
chr5:177557673-177557674 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs547486357 |
chr5:177557696-177557697 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs560830544 |
chr5:177557709-177557710 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs115175414 |
chr5:177557760-177557761 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs552330923 |
chr5:177557786-177557787 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs145125773 |
chr5:177557821-177557822 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionCpG islandChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs11445687 |
chr5:177557826-177557827 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'
|
TF binding regionCpG islandChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|